Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
European Journal of Nuclear Medicine and Molecular Imaging
Published in: European Journal of Nuclear Medicine and Molecular Imaging 5/2011

01-05-2011 | Image of the Month

FDG PET coregistered to MRI for diagnosis and monitoring of therapeutic response in aggressive phenotype of sarcoidosis

Authors: Alessio Imperiale, Sophie Riehm, Francis Veillon, Izzie-Jacques Namer, Jean-Jacques Braun

Published in: European Journal of Nuclear Medicine and Molecular Imaging | Issue 5/2011

Login to get access

Excerpt

Neurosarcoidosis (NS) and sinonasal sarcoidosis (SNS) represent severe phenotypes of sarcoidosis requiring treatment [1‐3]. The potentiality of 18F-fluorodeoxyglucose (FDG) positron emission tomography (PET) has been scarcely evaluated in the clinical management of atypical and aggressive forms of sarcoidosis [3‐5]. …
Literature
1.
2.
Balan A, Hoey ETD, Sheerin F, Lakkaraju A, Chowdhury FU. Multi-technique imaging of sarcoidosis. Clin Radiol 2010;65:750–60.PubMedCrossRef
3.
Braun JJ, Imperiale A, Riehm S, Veillon F. Imaging in sinonasal sarcoidosis: CT, MRI, 67Gallium scintigraphy and 18F-FDG PET/CT features. J Neuroradiol 2010;37:172–81.PubMedCrossRef
4.
Aide N, Benayoun M, Kerrou K, Khalil A, Cadranel J, Talbot JN. Impact of [18F]-fluorodeoxyglucose ([18F]-FDG) imaging in sarcoidosis: unsuspected neurosarcoidosis discovered by [18F]-FDG PET and early metabolic response to corticosteroid therapy. Br J Radiol 2007;80:e67–71.PubMedCrossRef
5.
Braun JJ, Kessler R, Constantinesco A, Imperiale A. 18F-FDG PET/CT in sarcoidosis management: review and report of 20 cases. Eur J Nucl Med Mol Imaging 2008;35:1537–43.PubMedCrossRef
Metadata
Title
FDG PET coregistered to MRI for diagnosis and monitoring of therapeutic response in aggressive phenotype of sarcoidosis
Authors
Alessio Imperiale
Sophie Riehm
Francis Veillon
Izzie-Jacques Namer
Jean-Jacques Braun
Publication date
01-05-2011
Publisher
Springer-Verlag
Published in
European Journal of Nuclear Medicine and Molecular Imaging / Issue 5/2011
Print ISSN: 1619-7070
Electronic ISSN: 1619-7089
DOI
https://doi.org/10.1007/s00259-010-1725-5

Other articles of this Issue 5/2011

European Journal of Nuclear Medicine and Molecular Imaging 5/2011 Go to the issue

Original Article

Bone metabolic activity in hyperostosis cranialis interna measured with 18F-fluoride PET

Original Article

Quantification of neutrophil migration into the lungs of patients with chronic obstructive pulmonary disease

Society communications

EANM Marie-Curie Training Project Report 2011 University Medical Centre Charité Berlin Ivayla Apostolova

Original Article

Measuring response to therapy using FDG PET: semi-quantitative and full kinetic analysis

Letter to the Editor

Does hybrid diagnostic imaging in cardiology have the same significance as in oncology?

Original Article

Functional imaging in phaeochromocytoma and neuroblastoma with 68Ga-DOTA-Tyr3-octreotide positron emission tomography and 123I-metaiodobenzylguanidine